SI-Bone(NASDAQ) SIBN

SI-BONE, Inc. makes implants for lower back pain. These tools help stabilize the spine and pelvic bones. The company supports surgeons who treat bone injuries.

Tools for Bone Health

• iFuse: Triangular titanium implants used to fuse the sacroiliac joint, which connects the spine to the pelvis.
• iFuse-3D: Porous titanium implants made with three-dimensional printing to encourage bone growth around the device.
• iFuse-TORQ: Threaded screw implants used specifically to treat pelvic fractures and stabilize the sacropelvic region.

A Growing Sales Network

• Increased the U.S. sales force to more than 175 team members and 350 third-party agents as of June 30, 2026.
• Expanded sales to ambulatory surgical centers and office-based labs, which are medical facilities that perform outpatient procedures.
• Signed an operating lease for a new office building in San Jose, California, in Feb. 2026.
• Developed three platform technologies that earned breakthrough device designations from the U.S. Food and Drug Administration.

Focus on the Pelvis

SI-BONE focuses on the sacropelvic region, which is the area where the spine meets the pelvis. Its products have been used in more than 150,000 procedures since the company began selling its technologies.

Financial Facts and Figures

• Revenue reached $56.0 million for the three months ended June 30, 2026, up 15.2% year over year.
• U.S. revenue accounted for 95% of total sales during the second quarter of 2026.
• The company held $145.9 million in cash and marketable securities as of June 30, 2026.
• Net loss was $8.4 million for the six-month period ended June 30, 2026.
• Average annual revenue per territory sales manager rose to $2.2 million for the 12 months ended June 30, 2026.

The Evolution of SI-BONE

SI-BONE has evolved from a startup focused on a single joint into a specialized medical device company with a broad platform for pelvic and spinal health. Its focus on clinical evidence and surgical efficiency supports its growth in the orthopedic market.